BIVI
Price:
$1.76
Market Cap:
$13.27M
BioVie Inc. is a clinical-stage biotechnology firm primarily dedicated to the discovery, development, and commercialization of innovative drug treatments across the United States. The company's developmental portfolio includes BIV201, a therapeutic agent that has successfully completed its Phase IIa clinical trial for addressing ascites resulting from chronic liver cirrhosis. Additionally, BioVie is advancing NE3107, which is currently undergoing a Phase III clinical trial for the management of mild to moderate Alzheimer's disease, and is also in a Phase I clinical trial for the treatment of Parkinson's disease. Further preclinical investigations are underway for NE3107, exploring its potent...[Read more]
Industry
Biotechnology
IPO Date
2020-09-18
Stock Exchange
NASDAQ
Ticker
BIVI
According to BioVie Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.47. This represents a change of -288.31% compared to the average of 0.25 of the last 4 quarters.
The mean historical PE Ratio of BioVie Inc. over the last ten years is -11.51. The current -0.47 PE Ratio has changed 308.45% with respect to the historical average. Over the past ten years (40 quarters), BIVI's PE Ratio was at its highest in in the June 2025 quarter at 2.36. The PE Ratio was at its lowest in in the March 2021 quarter at -219.77.
Average
-11.51
Median
-2.08
Minimum
-72.70
Maximum
-0.57
Discovering the peaks and valleys of BioVie Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 469.16%
Maximum Annual PE Ratio = -0.57
Minimum Annual Increase = -89.09%
Minimum Annual PE Ratio = -72.70
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | -0.76 | 33.86% |
| 2024 | -0.57 | -79.54% |
| 2023 | -2.79 | 103.67% |
| 2022 | -1.37 | 19.63% |
| 2021 | -1.14 | -44.03% |
| 2020 | -2.04 | -83.10% |
| 2019 | -12.09 | 469.16% |
| 2018 | -2.12 | -89.09% |
| 2017 | -19.48 | -73.21% |
| 2016 | -72.70 | -22.30% |
The current PE Ratio of BioVie Inc. (BIVI) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-1.37
5-year avg
-1.33
10-year avg
-11.51
BioVie Inc.’s PE Ratio is greater than Kazia Therapeutics Limited (-1.91), less than PMGC Holdings Inc. (-0.01), greater than Can-Fite BioPharma Ltd. (-686.14), less than CERo Therapeutics Holdings, Inc. (-0.00), less than Theriva Biologics, Inc. (-0.10), less than Galmed Pharmaceuticals Ltd. (-0.25), less than Ocean Biomedical, Inc. (-0.00), less than Artelo Biosciences, Inc. (-0.07), less than InMed Pharmaceuticals Inc. (-0.00), less than Lipella Pharmaceuticals Inc. (-0.03),
| Company | PE Ratio | Market cap |
|---|---|---|
| -1.91 | $22.45M | |
| -0.01 | $2.69M | |
| -686.14 | $1.60M | |
| -0.00 | $13.26K | |
| -0.10 | $8.96M | |
| -0.25 | $3.18M | |
| -0.00 | $118.64K | |
| -0.07 | $2.94M | |
| -0.00 | $2.70M | |
| -0.03 | $369.67K |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like BioVie Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like BioVie Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is BioVie Inc.'s PE Ratio?
How is the PE Ratio calculated for BioVie Inc. (BIVI)?
What is the highest PE Ratio for BioVie Inc. (BIVI)?
What is the 3-year average PE Ratio for BioVie Inc. (BIVI)?
What is the 5-year average PE Ratio for BioVie Inc. (BIVI)?
How does the current PE Ratio for BioVie Inc. (BIVI) compare to its historical average?